A volunteer panel the size of a city...

Posted:

November 2013

We are able to recruit even rare trial populations fast and reliably.Our database is exclusive to people actively seeking to take part in clinical trials. This is a significant improvement over most databases of patients as these contain a majority of patients who are reluctant to participate in a clinical study.

Tell us about your recruitment needs

Write to us at info@richmondpharmacology.com
Or click here for contact and enquiries

Alternatively, please browse through our website for more information on our full range of services.

Back to news

More about us Adaptive Phase I, II & III Bridging Studies TQT Studies Patient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021

Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.

View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021

Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.

A new era for UK-Japanese scientific relations

March 23, 2021

Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021

Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London